Efficacy and safety of the vasopressin antagonist conivaptan in patients with euvolemic hyponatremia evaluated in a phase III clinical trial

8550 Background: Hyponatremia, often caused by the inappropriate secretion of arginine vasopressin (AVP), is a common electrolyte disorder in patients with small-cell lung cancer (15%), head and ne...